You are here

  • Home
  • Archive
  • Volume 10, Issue 7
  • Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer

Citation Tools

Article menu
Clinical/translational cancer immunotherapy
Original research
Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Ye J, Mills BN, Qin SS, et al
Toll-like receptor 7/8 agonist R848 alters the immune tumor microenvironment and enhances SBRT-induced antitumor efficacy in murine models of pancreatic cancer
Journal for ImmunoTherapy of Cancer 2022;10:e004784. doi: 10.1136/jitc-2022-004784